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Lipoproteins fulfill diverse roles in antibiotic resistance, adhesion, protein secretion,
signaling and sensing, and many also serve as the substrate binding protein (SBP)
partner to ABC transporters for the acquisition of a diverse array of nutrients including
peptides, sugars, and scarcely abundant metals. In the staphylococci, the iron-regulated
SBPs are significantly upregulated during iron starvation and function to sequester and
deliver iron into the bacterial cell, enabling staphylococci to circumvent iron restriction
imposed by the host environment. Accordingly, this subset of lipoproteins has been
implicated in staphylococcal pathogenesis and virulence. Lipoproteins also activate the
host innate immune response, triggered through Toll-like receptor-2 (TLR2) and, notably,
the iron-regulated subset of lipoproteins are particularly immunogenic. In this review, we
discuss the iron-regulated staphylococcal lipoproteins with regard to their biogenesis,
substrate specificity, and impact on the host innate immune response.
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INTRODUCTION
The staphylococci are a diverse group of Gram-positive,
catalase-positive facultative anaerobes, consisting of approxi-
mately 36 species hosted largely by the human body (Kloos
and Bannerman, 1994). Historically, the staphylococci have been
broadly divided into two groups based on their coagulase activ-
ity with Staphylococcus aureus representing the most notable,
coagulase-positive pathogen of the genus. S. aureus is often
regarded as the leading cause of infections of the bloodstream,
skin, soft tissue, and lower respiratory system (Moet et al.,
2007). In contrast, coagulase-negative staphylococci (CoNS) were
largely considered to be harmless commensals of the skin and
mucous membranes until recent years, when the opportunisti-
cally pathogenic S. epidermidis has emerged as the most frequent
cause of device-associated nosocomial infections (reviewed in
Otto, 2012). The appearance of vancomycin-resistance in clinical
isolates of both S. aureus and CoNS, in addition to the increas-
ing prevalence of community-associated methicillin-resistant S.
aureus (CA-MRSA), highlights the continued need to develop
novel strategies to combat these global pathogens (Srinivasan
et al., 2002; Vandenesch et al., 2003).
The success of the staphylococci has been attributed, in part,
to their ability to acquire iron from the host. In contrast to its
relative abundance in nature, iron represents a severely growth-
limiting nutrient in vivo. Indeed, while the solubility for ferric
iron is often cited as 10−18 M, an adjusted calculation suggests
that the actual concentration is closer to 10−9–10−10 M at neu-
tral pH in aerobic environments, based on Fe(OH)+2 being the
primary species instead of Fe(OH)3 (Ratledge and Dover, 2000).
The revised value is still orders of magnitude lower than required
to support microbial growth and additionally, iron within the
host is further sequestered in glycoproteins such as transferrin
and lactoferrin, boundwithin storage proteins such as ferritin and
hemosiderin, or complexed with heme in the form of hemoglobin
and myoglobin (Ratledge, 2007). Sequestration of iron functions
both in preventing the catalysis of reactions generating damag-
ing free radicals and in providing nutritional immunity against
bacterial infection (Schaible and Kaufmann, 2004).
To circumvent the aforementioned restrictions, the staphylo-
cocci have evolved a plethora of mechanisms to acquire iron from
the host, including the elaboration of multiple siderophores, uti-
lization of xenosiderophores, acquisition of iron from heme and
hemoproteins, and the uptake of inorganic free iron (Beasley
and Heinrichs, 2010; Haley and Skaar, 2012; Hammer and
Skaar, 2011). Each of these systems employs an iron-regulated
membrane protein, almost always of the ATP-binding cassette
(ABC) transporter superfamily, for import of iron or complexed-
iron across the membrane. In addition to the required ABC-
type membrane permease and ATPase (Davidson et al., 2008),
these iron-regulated ABC transporters employ a high-affinity
membrane-anchored lipoprotein, i.e., a protein bearing an
N-terminal, covalently linked lipid (Hutchings et al., 2009), for
the specific recognition and binding of the iron substrate; these
lipoproteins are analogous to the periplasmic substrate bind-
ing proteins (SBPs) of Gram-negative bacteria. Acylation of the
hydrophilic protein promotes localization of the lipid into the
phospholipid bilayer, anchoring the protein in close proximity to
the membrane where it is positioned, once bound by substrate,
to interact with its cognate ABC transporter to facilitate translo-
cation of substrate into the cell. Whereas many other functions
have been attributed to lipoproteins in bacteria, including sensing
and signaling, protein secretion, antibiotic resistance, adhesion
and the uptake of many nutrients in addition to iron (Sutcliffe
and Russell, 1995), herein we focus attention solely on the iron-
regulated lipoproteins (IRLPs) expressed by the staphylococci,
given their important roles in staphylococcal pathogenesis and
immune stimulation. Of the approximately 50 total lipoproteins
encoded by S. aureus, the species in which most of the work has
been performed, studies from several laboratories have identified,
to date, a total of 9 IRLPs—SirA, HtsA, SstD, FhuD1, FhuD2,
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IsdE, FepA, SitC, and Opp1A. These proteins will be the subject
of this review.
CONTROL OF IRON-REGULATED GENE EXPRESSION
Fur
The f erric uptake regulator (Fur) is a homodimeric metallopro-
tein that functions as a transcriptional regulator of iron home-
ostasis in many bacteria. When complexed with iron, Fur regu-
lates the transcription of genes by binding a 19-bp inverted repeat
sequence (5′-GATAATGATAATCATTATC-3′), known as the Fur
box, within the operator/promoter region (Escolar et al., 1999;
Baichoo and Helmann, 2002). The Fur protein mainly functions
as a repressor, mediating global suppression of iron-responsive
genes in response to iron-replete conditions (Xiong et al., 2000;
Hantke, 2001; Baichoo et al., 2002). Among the Fur-repressed
genes are those involved in iron acquisition; Fur-boxes control-
ling expression of staphylococcal IRLPs are shown in Figure 1A.
Binding of Fur to the Fur box sequences is dependent upon
concomitant Fe2+ binding to Fur and, together, the competent
DNA-binding complex blocks association of RNA polymerase
with promoters, thereby inhibiting transcription. Under iron
restriction, intracellular Fe2+ depletion results in dissociation of
Fur from DNA, allowing transcription to proceed.
SirR/MntR
The notable exception to Fur regulation of the IRLPs is the
staphylococcal iron transporter, SitABC/MntABC. SitABC and
SirR were initially discovered in S. epidermidis (Cockayne et al.,
1998), and in Bacillus subtilis where the SitABC and SirR homo-
logues were named MntABCD and MntR, respectively, based
on work of Helmann and colleagues in confirming their role in
manganese uptake and homeostasis (Que and Helmann, 2000;
Glasfeld et al., 2003; Lee and Helmann, 2007). The homolo-
gous region in S. aureus was likewise identified and referred to
as MntABC and MntR (Horsburgh et al., 2002). Expression of
sitABC/mntABC is controlled by the diphtheria toxin repressor
(DtxR)-like homologue, SirR/MntR (Hill et al., 1998; Horsburgh
et al., 2002; Ando et al., 2003). Transcription of sitABC is
repressed by SirR in the presence of either Mn2+ or Fe2+ in S.
epidermidis (Hill et al., 1998), although there is some contention
over whether both Mn2+ or Fe2+, or just Mn2+ controls expres-
sion in S. aureus (Horsburgh et al., 2002; Ando et al., 2003).
Like with Fur, transcription is blocked in the presence of these
divalent metal ions because the metal ions facilitate the binding
of SirR/MntR to a conserved SirR (or MntR) box (Figure 1A),
a region of dyad symmetry in the promoter/operator region of
sitABC/mntABC (Hill et al., 1998; Ando et al., 2003). Repression
of transcription is relieved when the metal ion concentration is
depleted.
LIPOPROTEIN BIOGENESIS
A detailed and comprehensive analysis of lipoprotein biogen-
esis is outside the scope of this review, but we refer the
reader to a recent review, and references therein, for an excel-
lent summary of lipoprotein biogenesis in bacterial pathogens
(Kovacs-Simon et al., 2011). Bacterial preprolipoproteins bear
both an N-terminal signal peptide, characteristic of secreted
FIGURE 1 | S. aureus Fur boxes, SirR/MntR box, and IRLP signal
peptides. (A) Fur box sequences within the promoter/operator region of
operons encoding the indicated S. aureus SBP-encoding gene and the
SirR/MntR box located upstream of sitC/mntC. (B) Signal peptides for the
indicated IRLPs, with the lipobox indicated by the box. Nucleotide and
protein sequences are all derived from S. aureus COL.
proteins, and, within the C-region of the signal peptide, a con-
served sequence [L/V/I]−3 − [A/S/T/V/I]−2 − [G/A/S]−1 −
C+1 which is referred to as the lipobox motif (see Figure 1B
for lipobox motif of S. aureus IRLPs) (Kovacs-Simon et al.,
2011). In the first biogenesis reaction, the lipoprotein diacyl-
glyceryl transferase (Lgt) covalently links a diacylglycerol moiety
to the thiol group on the side chain of the essential +1 cys-
teine of the lipobox. The subsequent reaction involves the cleav-
age of the signal peptide from the diacylated prolipoprotein by
lipoprotein signal peptidase (Lsp; alternatively called signal pep-
tidase II), an activity that appears contingent upon lipidation
by Lgt in Gram-negative bacteria (Tokunaga et al., 1982), but
is not a prerequisite in Gram-positive bacteria (Baumgartner
et al., 2007). In a third reaction, highly conserved among Gram-
negative bacteria and the Actinomycetes, the enzyme lipoprotein
N-acyl transferase (Lnt) catalyzes the addition of a third fatty
acid to the free amino group of the cysteine, resulting in a tri-
acylated protein. With few exceptions, the lgt, lsp, and lnt genes
are indispensible in Gram-negative bacteria, yet in contrast, these
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genes are dispensable in Gram-positive bacteria (reviewed in
Kovacs-Simon et al., 2011).
Given the apparent lack of lnt homologues within Firmicute
genomes, it was presumed that lipoproteins within this phy-
lum were diacylated, a notion supported by the identification of
diacylated lipoproteins among the staphylococci (Tawaratsumida
et al., 2009). In contradistinction, SitC (MntC), the predomi-
nant lipoprotein of S. aureus and SBP for SitABC (MntABC),
was found to be triacylated in multiple S. aureus strains and
in S. epidermidis (Kurokawa et al., 2009; Asanuma et al., 2011).
Furthermore, four other major staphylococcal lipoproteins were
found to be triacylated (Asanuma et al., 2011), including the same
lipoprotein earlier identified to be diacylated by Tawaratsumida
et al. (2009). The discrepancies between these studies could
be attributed to differences in culture conditions and prepa-
ration of the lipoproteins, given that Asanuma et al. noted a
minor presence of diacylated SitC (MntC) lipopeptides in cul-
tures grown at elevated temperatures (Asanuma et al., 2011).
The notion of global N-acylation among the Firmicutes is fur-
ther bolstered by a recent report of triacylated lipoproteins
among the class Mollicute in Acholeplasma laidlawii, despite
the lack of a recognizable Lnt homolog in this bacterium
(Serebryakova et al., 2011). Consequently, the nature by, and
degree to which, staphylococcal lipoproteins are N-acylated
remains unknown, and it is possible that an as-yet unidenti-
fied enzyme, with no similarity to Gram-negative Lnt enzymes,
exists within the Firmicutes that is responsible for this elusive
activity.
THE STAPHYLOCOCCAL IRLPs: FUNCTIONS IN IRON
ACQUISITION
The thus-far identified nine IRLPs in the staphylococci are
involved in, or at least implicated in, the uptake of iron through
either siderophore (Figure 2A) or non-siderophore (Figure 2B)
based systems. Together, these systems engender staphylococci
with versatility in that they are able to recognize and utilize a
broad range of iron substrates. Unsurprisingly, the common func-
tion of these IRLP is reflected in their largely conserved overall
protein structure.
As a result of a recent revisitation of the classification
scheme to segregate SBPs based upon structural characteristics
(Berntsson et al., 2010), the majority of the staphylococcal IRLPs,
with the exception of FepA and Opp1A (discussed below), fall
into cluster A, which consists of class III SBPs associated with ABC
transporters. These proteins have an approximately 20 residue
long α-helical backbone that joins two independently folded
domains, each of which consists of central β-strands surrounded
by α-helices; substrate is bound into the groove formed between
the two domains (Figure 3A). Relative to members of other SBP
clusters, hinge motion, upon binding of the substrate, between
the two domains of cluster A proteins is restricted by the helical
spine. Docking of the cluster A SBPs with their cognate mem-
brane ABC-type permeases is facilitated by salt-bridges formed
between conserved glutamic acid residues on the lobes of the SBP
(Figure 3A) and patches of positive charge on the exterior sur-
face of the permease, formed by three conserved arginine/lysine
residues (Borths et al., 2002).
HtsA AND SirA—RECEPTORS FOR THE FERRATED
STAPHYLOFERRIN SIDEROPHORES
Siderophores are secreted, low-molecular-weight molecules that
have high-affinity for ferric iron. Among members of the staphy-
lococci, two siderophoresmay be produced, staphyloferrin A (SA)
and staphyloferrin B (SB) (Konetschny-Rapp et al., 1990; Meiwes
et al., 1990; Drechsel et al., 1993; Haag et al., 1994). Enzymes for
the synthesis of SA and SB are encoded from the sfaABCD and
sbnABCDEFGHI loci, respectively (Dale et al., 2004a,b; Beasley
et al., 2009; Cheung et al., 2009; Cotton et al., 2009) (Figure 2A).
Adjacent to each of these biosynthetic loci, but transcribed sepa-
rately, are operons encoding the requisite ABC-transporters for
uptake of Fe-SA and Fe-SB complexes (Dale et al., 2004a,b;
Beasley et al., 2009, 2011; Beasley and Heinrichs, 2010). The
transport systems for the two siderophores have been shown to be
non-interchangeable, where HtsABC specifically uptakes Fe-SA
and SirABC specifically uptakes Fe-SB (Beasley et al., 2009).While
each of the transporter-encoding operons codes for a SBP (HtsA
and SirA) and a heterodimeric permease component (HtsBC and
SirBC), both lack a gene encoding the ATPase component of the
ABC transporter. Instead, at least in S. aureus, FhuC, expressed
from the fhuCBG operon (Figure 2A) serves as the ATPase for
import of both Fe-SA and Fe-SB (Speziali et al., 2006; Beasley
et al., 2009). The notion of a common ATPase between multiple
iron acquisition pathways is not unprecedented; the YusV ATPase
in B. subtilis acts in the uptake of siderophores through both
feuABC and yfiYZyfhA (Ollinger et al., 2006). Currently available
genomic sequences reveal that while the hts-sfa locus is found in
all staphylococcal genomes (incl. S. aureus, S. epidermidis, S. lug-
dunensis, S. saprophyticus, S. haemolyticus, S. pseudintermedius,
S. warneri, S. capitis, S. caprae, S. hominis, S. carnosus and S.
xylosus), the sir-sbn locus is only found in the genomes of S.
aureus and S. pseudintermedius. Curiously, however, SB was iden-
tified in the supernatants of several members of CoNS, and was
first identified in coagulase-variable S. hyicus (Konetschny-Rapp
et al., 1990; Meiwes et al., 1990; Drechsel et al., 1993); the rea-
son for the discrepancy between these findings and the available
genome information remains unknown. Genomes of S. lugdunen-
sis, although possessing htsABC, carry a deletion of sfaA and sfaD,
suggesting that this species may utilize Fe-SA as an iron source,
but likely does not synthesize either staphyloferrin molecule.
Given that both SA and SB are highly hydrophilic, α-
hydroxycarboxylate type siderophores (Beasley and Heinrichs,
2010), highly specific binding to their cognate receptors would
be necessary to maintain the aforementioned uptake specificity.
Without the specific recognition and binding of Fe-SA and Fe-
SB to HtsA and SirA, respectively, one might anticipate that
transporters for these structurally similar siderophores would
be interchangeable. Recent structural characterizations of both
HtsA and SirA have shed significant light on the reason for
this specificity. HtsA and SirA both adopt the bilobed, α-helical
backboned structure typical of the cluster A SBPs (see above),
and their binding pockets are shallow and basic to accommo-
date the negatively charged siderophores, yet few residues within
the substrate binding pocket are conserved between the two
lipoproteins (Grigg et al., 2010a,b). HtsA coordinates Fe-SA
through H-bonding between six arginine residues, directed into
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FIGURE 2 | Iron acquisition systems in S. aureus.
(A) Siderophore-dependent iron uptake systems.
(B) Siderophore-independent iron uptake systems. Each system is discussed
in the text. The open reading frame accession number, based on S. aureus
COL genome, for each of the IRLPs (blue) is indicated. The directionality
indicated for each of the genes is as in the genome. The red star represents
heme and the open star represents protoporphyrin IX. Hb, hemoglobin; Hp,
haptoglobin.
the binding pocket, and oxygen atoms in SA (Figure 3B) (Grigg
et al., 2010b). Conserved residue R125 also anchors Fe-SB in
SirA (Grigg et al., 2010a), however the remaining coordinating
residues are unique (Figure 3C). The number of coordinating
arginine residues is a reflection of the net negative charge on the
associated siderophore, where up to six are required to neutral-
ize the –5 net charge on SA, and three are required for the –3 net
charge of SB. Furthermore, while siderophore binding to HtsA
and SirA induces negligible hinge movement along the α-helix,
significant and specific conformational changes occur within the
C-terminal domain of both (Grigg et al., 2010a,b). The unique
coordinating residues, in addition to the distinct conformational
changes, likely maintain the specificity and affinity of these recep-
tors for their cognate siderophores, and it is unsurprising that
their ligand affinities fall within the nanomolar range (Grigg et al.,
2010a,b)
Inactivation of any of the individual biosynthetic or trans-
port loci for SA or SB yields an unimpressive, if any, phe-
notype when examining for defects in iron-restricted growth
(Beasley et al., 2009, 2011). However, the combined inactiva-
tion of either sbn together with sfa or sir together with hts yields
mutants with severe growth defects in serum (Beasley et al., 2009,
2011). Notably, the inactivation of multiple transport systems in
S. aureus results in decreased bacterial fitness during infection,
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FIGURE 3 | Representative structure of cluster A SBPs, and structures of
protein-bound Fe-SA and Fe-SB. (A) Representative ribbon diagram to
highlight some of the key characteristics of the cluster A SBPs, including the
helical spine (yellow) connecting the alpha/beta N-terminal (blue) and
C-terminal (red) lobes that surround the binding pocket (green triangle), and
the two conserved glutamic acid residues (black) that interact with the
membrane permease. (B) Structure of iron-bound staphyloferrin A with
coordinating residues from the S. aureus HtsA SBP (PDB 3LI2). (C) Structure
of iron-bound staphyloferrin B with coordinating residues from the S. aureus
SirA SBP (PDB 3MWF).
relative to inactivation of the corresponding biosynthetic loci
(Beasley et al., 2011), likely due to the continued production of
siderophores even in the absence of their cognate receptors, which
would enhance iron-starvation in vivo (Beasley et al., 2011).
Impairment of receptor function, therefore, represents a potential
avenue for therapeutic intervention (see below).
SstD—RECEPTOR FOR FERRATED
CATECHOLS/CATECHOLAMINES
Catechol siderophores, typified by the well-studied enterobactin
(or enterochelin), bacillibactin, vibriobactin and salmochelin, are
representative of a major class of bacterial siderophores (for a
review, see Miethke and Marahiel, 2007). Additionally, the ability
of catecholamine stress hormones to stimulate growth of bacteria,
including members of CoNS, in the presence of serum (i.e., trans-
ferrin) has been studied over the past decade (Freestone et al.,
2000, 2008; Neal et al., 2001). Indeed, recent work illuminated
how hormones such as epinephrine and norepinephrine are capa-
ble of reducing transferrin-bound ferric iron to ferrous iron and
thereby liberating iron from this central component of innate
immunity (Sandrini et al., 2010). While catechol siderophores
have not been identified in culture supernatants of staphylo-
cocci, staphylococci are capable of using both catechols and
catecholamines as an iron source via the SstABCD ABC trans-
porter (Beasley et al., 2011). The locus (Figure 2A), initially
identified through screens for iron-regulated staphylococcal anti-
gens (Morrissey et al., 2000), is highly conserved among S. aureus
strains and present in the majority of CoNS. The function of
this transporter remained uncharacterized until recently, when sst
mutations were characterized in staphyloferrin-deficient strains
(Beasley et al., 2011). The sst locus is required for growth pro-
motion by catechol siderophores and catecholamine-liberated
transferrin iron, and contributes to in vivo colonization of the
murine liver and kidneys. With the exception of the colonization
of murine hearts, these in vivo and in vitro effects were otherwise
masked in strains synthesizing the staphyloferrins (Beasley et al.,
2011).
SstD specifically binds both ferrated catechol siderophores and
catecholamine stress hormones with micromolar and submicro-
molar affinities (Beasley et al., 2011). The reduced affinity of SstD
for its ligands, relative to SirA and HtsA, is likely a trade-off in
favor of an enhanced range of potential substrates. The closest
homologs to SstD include the YclQ protein from B. subtilis and
the CeuE protein from Campylobacter jejuni. Structural infor-
mation exists for these proteins in complex with their ligands;
YclQ binds the “stealth” siderophore petrobactin (Zawadzka et al.,
2009), while CeuE binds iron complexed by the enterobactin
analog, mecam (Muller et al., 2006). Some conservation in the
binding mechanism of these proteins is indicated by shared
binding pocket residues between SstD, CeuE, and YclQ, which
in CeuE interact with the mecam substrate. Crystallographic
information for liganded SstD unfortunately remains lacking,
but this information would afford insight into the mecha-
nism by which this receptor binds a diverse range of catechol
ligands.
FhuD1 AND FhuD2—RECEPTORS FOR FERRIC-HYDROXAMATE
SIDEROPHORES
While the staphylococci have not been demonstrated to synthe-
size hydroxamate-type siderophores, they are known to be able
to utilize them as iron sources. These include aerobactin (pro-
duced by some enterobacteriaceae), ferrichrome (produced by
the basidiomycete fungus Ustilago sphaerogena), coprogen (pro-
duced by Neurospora crassa), and desferrioxamine B, produced
by Streptomyces pilosus; the mesylate salt of desferrioxamine B is
used clinically under the name Desferal™ (Brock and Ng, 1983;
Sebulsky et al., 2000; Sebulsky and Heinrichs, 2001). Uptake of
multiple hydroxamate-type siderophores was similarly demon-
strated for B. subtilis (Schneider and Hantke, 1993), and a homol-
ogous system identified in the S. aureus (Sebulsky et al., 2000).
Ferric-hydroxamate uptake is achieved through the concerted
effort of the FhuC ATPase, FhuBG heterodimeric permease, and
the independently transcribed substrate-binding lipoproteins,
FhuD1 and FhuD2 (Figure 2A) (Sebulsky et al., 2000; Sebulsky
and Heinrichs, 2001). All species of staphylococci, with the possi-
ble exception of S. hominis and S. xylosus, possess the Fhu uptake
system.
While many hydroxamate ligands are common between
FhuD1 and FhuD2, the two lipoproteins do possess some unique
substrate specificities with FhuD2 exhibiting both a wider range
of ligands and greater substrate affinity than FhuD1 (Sebulsky
et al., 2003, 2004). While FhuD1 appears to be a less effective
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Fe3+-siderophore SBP than FhuD2, it is certainly possible that the
substrates and/or conditions under which FhuD1 are optimal are
not defined. While the structures of FhuD1 and FhuD2 are not
yet available, structures have been determined for E. coli FhuD
bound to several hydroxamate ligands (Clarke et al., 2000, 2002).
In contrast to the binding pocket of proteins such as SirA and
HtsA, which harbor key charged residues that interact with the
siderophoremolecule, the structures of E. coli FhuD show that the
binding of ligands is largely dependent upon hydrophobic con-
tacts; accommodation of several different hydroxamate substrates
occurs only through subtle rearrangements of the FhuD protein
side-chains.
IsdE—A HEME RECEPTOR
isdE homologues have been identified in several Gram-positive
pathogens including S. aureus, S. lugdunensis, Bacillus anthracis,
Clostridium tetani, and Listeria monocytogenes (Skaar and
Schneewind, 2004; Heilbronner et al., 2011). The iron-regulated
surface determinant pathway (Isd) represents the predominant
system for iron acquisition from heme and hemoproteins in
S. aureus (Mazmanian et al., 2002, 2003). The proposed architec-
tural arrangement of the nine Isd proteins, facilitated by anchor-
ing to the cell wall through sortase A activity (for IsdA, IsdB,
and IsdH), and isd locus-encoded sortase B activity (for IsdC),
allows for heme, extracted from hemoglobin or haptoglobin-
hemoglobin, at the cell surface to be shuttled proximal to the
membrane where it is bound by the SBP IsdE, and transported
into the cytoplasm through the ABC permease IsdF (Figure 2B)
(Mazmanian et al., 2003; Skaar and Schneewind, 2004; Torres
et al., 2006; Muryoi et al., 2008; Zhu et al., 2008; Grigg et al.,
2010c). Once in the cytoplasm, heme may be degraded by IsdG
and IsdI, releasing iron (Skaar et al., 2004a,b; Lee et al., 2008).
As a member of the cluster A SBPs (see above), IsdE possesses
the characteristics depicted in Figure 3A but, unlike SirA and
HtsA, bears a deep hydrophobic groove between the two lobes
comprising a heme binding pocket (Grigg et al., 2007). A single
intermediate or high-spin ferric or, preferentially, low-spin fer-
rous heme molecule is coordinated by the axial ligands H229 and
M78 (Grigg et al., 2007; Pluym et al., 2007). As with several of the
other iron ABC transporters in the staphylococci, the isdEF genes
are not genetically linked with a gene encoding the obligatory
ATPase for the transporter. It is possible that the promiscuous
FhuC drives transport through IsdEF.
In vitro experiments using purified proteins demonstrated
that IsdE could receive heme directly from IsdC (depicted in
Figure 2B), as part of a larger study that provided support to the
notion that the Isd proteins act together as a heme shuttle sys-
tem within the bacterial cell wall and membrane (Muryoi et al.,
2008). Moreover, growth impairment has been demonstrated
for Isd mutants cultured on hemoglobin as a sole iron source
(Torres et al., 2006; Pishchany et al., 2009, 2010); subsequent
to hemoglobin binding at the cell surface and heme extraction,
heme is likely never free from a protein and is shuttled through
the wall and membrane via direct Isd-Isd protein contacts. On
the contrary, it should be noted, that an isdE mutation had less
of an impact when cultured in the presence of heme as a sole
iron source (Grigg et al., 2007). The lack of a marked phenotype
for the isdE mutant on heme raises the likely possibility that
when presented with free heme, a growth-supporting amount
of heme makes its way through the cell wall, bypassing the Isd
proteins, and is taken into the cell via non-specific mechanisms
or by secondary heme transporters, a notion currently under
investigation.
FepA—AN IRON RECEPTOR
The translocation of staphylococcal preprolipoproteins was ini-
tially thought to occur exclusively through the dominant secre-
tory pathway, Sec (Driessen and Nouwen, 2008; Natale et al.,
2008). However, the twin-arginine translocation pathway (Tat) is
another means of lipoprotein translocation across the membrane
in a number of Gram-positive, high GC bacteria (McDonough
et al., 2005; Widdick et al., 2006, 2011; Thompson et al., 2010),
and was recently identified in some (incl. S. aureus, S. haemolyti-
cus and S. carnosus), but not all, staphylococcal genomes. Pre-
folded proteins bearing a twin arginine motif in their signal pep-
tide are secreted by Tat (Meissner et al., 2007; Biswas et al., 2009),
however the role of Tat in the staphylococci appears limited both
in the apparent lack of complete Tat homologues in many CoNS,
such as S. epidermidis and S. saprophyticus, and in identified sub-
strates (Yamada et al., 2007; Biswas et al., 2009). Currently, the
sole identified substrate of Tat is the iron-dependent DyP-family
peroxidase, FepB (Biswas et al., 2009).
Dye-decolorizing (DyP)-type peroxidases form a unique heme
peroxidase family (for a review, see Sugano, 2009), and members
of the family have been reported to have several different sub-
strates (Letoffe et al., 2009; Ahmad et al., 2011; Liers et al., 2011).
Insofar as iron uptake is concerned, two Dyp paralogs in E. coli,
namely YfeX and EfeB (cytoplasmic and periplasmic enzymes,
respectively), were reported to have deferrochelatase activity on
heme (Letoffe et al., 2009). Deferrochelation would provide bac-
teria with an iron source in the absence of dedicated heme uptake
systems, however this is currently a subject of some debate. A
recent study has argued that the E. coli YfeX protein is not a
heme deferrochelatase but rather is a peroxidase that oxidizes por-
phyrinogens to porphyrins (Dailey et al., 2011). Should DyP-type
peroxidases bear deferrochelatase activity, it is possible that, like
YfeX and EfeB, staphylococcal FepB could also serve to release
ferrous iron from heme.
In addition to FepB, the fepABC operon, located adjacent to
tatAC, encodes an iron permease (FepC) and a putative iron-
binding lipoprotein (FepA) (Figure 2B). The exact function of
S. aureus fepABC in iron acquisition is still under investigation,
and the substrate specificity of FepA has not yet been determined.
Free ferrous iron released through the potential deferrocheletase
activity of FepB could serve as a substrate for FepAC, similar to
E. coli ferrous iron-specific efeUOB, which has been shown to
be induced by growth in aerobic, low pH and low iron condi-
tions (Grosse et al., 2006; Cao et al., 2007). Alternatively, fepABC
may function in elemental iron uptake in a manner analogous to
the Ftr1p/Fet3p ferric iron permease in Saccharomyces cerevisiae,
where Fe2+ is oxidized to Fe3+ by the multicopper oxidase, Fet3p,
and is subsequently transported into the cell by Ftr1p (Kwok et al.,
2006). A similar mechanism was first proposed in B. subtilis for
ywbLMN, a fepABC homologue, and, accordingly, the ywbLMN
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operon was shown essential to the normal growth of B. sub-
tilis in iron-restricted media (Ollinger et al., 2006; van der Ploeg
et al., 2011). Regardless, the presence of fep operon homologs
in many different bacteria, including both Gram-positive and
Gram-negative species, suggests a conserved and important func-
tionality. Indeed, S. aureus fep-tat mutants are impaired in inor-
ganic iron uptake and virulence in a murine renal abscess model
(Biswas et al., 2009).
Although no structure of a staphylococcal FepA protein has yet
been solved, homology searches and structural modeling indicate
that it is rather unique among the IRLPs. The closest homologs
to FepA are members of the imelysin-like superfamily (Xu et al.,
2011). The canonical imelysin fold is all-helical, comprising two
similar four-helix bundle domains with a predicted functional site
at the domain interface (Xu et al., 2011). Specifically, a conserved
GxHxxE motif, also present in staphylococcal FepA proteins,
is located at the open end of the binding cleft; this motif has
been implicated in the coordination of divalent metal cations
(Rajasekaran et al., 2010a,b; Xu et al., 2011). With well over 100
members, the imelysin-like proteins are widely distributed in bac-
teria and are virtually always located next to a gene encoding
a DyP-type peroxidase. Although biochemical evidence is still
lacking, this reinforces the assumption that the FepABC-like sys-
tems are involved in iron uptake, where the peroxidase potentially
converts ferrous iron to ferric iron, which is the ligand for the
FepA-like binding proteins.
Opp1A
Despite being annotated as an oligopeptide permease,
opp1ABCDF has no defined role in nitrogen metabolism
(Hiron et al., 2007). However, Opp1A, the SBP of this complex,
was shown to be significantly upregulated during iron-starvation,
both by our laboratory (unpublished data) and others (Hempel
et al., 2011), consistent with the identification of a putative Fur
box upstream of Opp1A (Figure 1A). The role of oligopeptide
permeases in metal ion and heme acquisition is not unprece-
dented; S. aureus Opp2BCDF and the orphan SBP Opp5A were
recently renamed NikBCDE and NikA due to their role in nickel
acquisition (Hiron et al., 2010), whereas in E. coli a di-peptide
permease is involved in the uptake of both nickel and heme
(DppA) (Letoffe et al., 2006, 2008; Shepherd et al., 2007). A
potential role for Opp1A in iron acquisition is currently under
investigation.
The opp1ABCDF operon encodes a prototypical oligopeptide
permease: two homologous permease proteins (OppB andOppC)
and two ATP-binding proteins (OppD and OppF), in addition to
the peptide/SBP (Figure 2B). Like FepA, Opp1A is not a member
of the cluster A SBPs, but instead is a member of cluster C which
includes oligopeptide, di-peptide and nickel binding proteins
(Berntsson et al., 2010). Cluster C members are characterized
by a larger size (approx. 50–70 kDa) than the cluster A proteins
(which are typically in the 30–35 kDa range), a large binding cav-
ity, an extra domain that augments the binding cavity - in some
cases to accommodate larger peptide ligands, and ligand binding
via a “Venus flytrap” mechanism (Berntsson et al., 2009, 2010).
The latter point indicates that these proteins capture their sub-
strates through significant inter-domain hinge movement, unlike
the relative lack of inter-domainmovement afforded by the helical
spine of the cluster A SBPs (see above).
According to Hiron et al. (Hiron et al., 2007), S. aureus pos-
sesses two additional oligopeptide permeases (opp3 and opp4)
and one di/tri-peptide permease (dtpT), in addition to opp1 and
nikA/nikBCDE. While opp3 and dtpT are involved in nitrogen
metabolism (Hiron et al., 2007; Borezee-Durant et al., 2009), the
roles of opp1 and opp4 are unknown and none of the lipopro-
teins have been investigated to determine if, like E. coliNikA, they
are capable of binding multiple substrates. Although the role of
opp1 is unknown, it has been implicated, along with opp2 and
dtpT, in staphylococcal infectivity and survival through signature
tagged-mutagenesis studies (Mei et al., 1997; Coulter et al., 1998).
The exact mechanism by which these permeases contribute to
virulence, however, is not known.
SitC/MntC—RECEPTORS FOR IRON OR MANGANESE
SitC, the lipoprotein component of SitABC (Figure 2B), was
first described as an immunogenic iron-repressible cytoplasmic
membrane protein (IRMP) in S. epidermidis (Cockayne et al.,
1998). The 32-kDa S. epidermidis SitC protein was found both
to be expressed by S. epidermidis and to react strongly with anti-
bodies in pooled human peritoneal dialysate (HPD) (Williams
et al., 1988; Smith et al., 1991; Wilcox et al., 1991; Modun
et al., 1992). HPD, the byproduct of continuous ambulatory peri-
toneal dialysis (CAPD) for renal failure, represents a severely
iron-restricted environment (Wallaeys et al., 1986; Williams et al.,
1988). Expression of SitC by S. epidermidis and S. aureus isolates
known to cause peritonitis in CAPD patients highlighted a poten-
tial role for SitC in iron acquisition, and consequently in vivo
survival of the staphylococci.
Sequence analysis of SitC revealed that it bears homology both
to proteins involved in bacterial adhesion as well as to metal bind-
ing proteins (Cockayne et al., 1998). Two of the closest structural
homologs to SitC are cluster A SBPs: the zinc-binding TroA pro-
tein from Treponema pallidum (PDB 1TOA) and the manganese-
bindingMntC protein from Synechocystis sp. (PDB 1XVL). Given
this, and that SitC is lipid tethered to the cell membrane with dis-
tribution throughout the cell wall and minimal surface exposure
(Smith et al., 1991; Wilcox et al., 1991; Cockayne et al., 1998), it
is unlikely to play a role in bacterial adhesion, although involve-
ment in adhesion has not been conclusively disproven. Greater
surface exposure would be expected to promote adhesion, which
is seen with the adhesins to which SitC was initially likened, but
not for SitC itself (Jenkinson, 1992; Sutcliffe et al., 1993; Cockayne
et al., 1998). The relatively porous nature of the cell wall, how-
ever, would render SitC accessible to metal cations, such as Fe2+,
Mn2+ or Zn2+, as well as to antibodies. Additionally, the extracel-
lular release of lipoproteins during iron starvation, such as SitC,
would further contribute to immunogenicity (Cockayne et al.,
1998). Despite a proposed role in divalent metal uptake, the fact
that expression of sitC is repressed in the presence of excess Mn2+
or Fe2+ (Hill et al., 1998), and that SitC is highly expressed in vivo,
the substrate of SitC in S. epidermidis remains unknown.
In contrast to S. epidermidis, the sitABC homologue in
S. aureus has an identified function in the transport of Mn2+,
and was consequently namedmntABC (Horsburgh et al., 2002) to
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reflect this activity, following the nomenclature previously used
in B. subtilis (Que and Helmann, 2000). While the presence of
Mn2+ facilitates repression of mntABC through the DtxR-family
regulator, MntR (SirR) (see regulation section, above), the role
of iron in mntABC expression is still unclear (Horsburgh et al.,
2002; Ando et al., 2003). Furthermore, the structure and char-
acterization of the substrate binding properties of MntC (SitC)
have yet to be elucidated. Regardless, with MntC (SitC) being
identified as a predominant lipoprotein in S. aureus and S. epi-
dermidis, and the observation that lipoprotein-deficient mutants
are both inhibited in iron-restricted growth and in Toll-like recep-
tor 2 (TLR2) activation in the host, it is not surprising that MntC
(SitC) contributes an important role in staphylococcal pathogen-
esis and survival (Stoll et al., 2005; Bubeck Wardenburg et al.,
2006; Schmaler et al., 2009, 2010; Muller et al., 2010).
ROLES FOR IRLPs IN IMMUNE RECOGNITION
The recognition of bacterial invaders by the innate immune sys-
tem occurs through the identification of pathogen-associated
molecular patterns (PAMPs) by Toll-like receptors (TLRs). Of
the >10 human TLRs currently identified, TLR2, together with
the adapter molecule MyD88, represents the main responsive ele-
ment to Gram-positive cell wall components and, consequently,
staphylococcal infection (Takeuchi et al., 1999, 2000a,b). Until
recently, the predominant staphylococcal PAMP for induction of
TLR2 and a potent inducer of cytokine release was considered
to be lipoteichoic acid (LTA) (Schwandner et al., 1999; Morath
et al., 2001, 2005). However, it has been shown that the LTA frac-
tions in these experiments were likely contaminated by lipopro-
teins, the implied true stimuli for TLR2-mediated inflammation
(Hashimoto et al., 2006a,b, 2007). The generation of staphylo-
coccal lgt mutants (see biogenesis section, above) has revealed
that lipid modification of prelipoproteins is essential to maximal
activation of and subsequent NF-κB-dependent cytokine release
via TLR2-MyD88, both in vitro and in vivo (Stoll et al., 2005;
Bubeck Wardenburg et al., 2006; Kurokawa et al., 2009; Schmaler
et al., 2009). Conversely, an LTA-depleted mutant was still capa-
ble of inducing TLR2 (Kurokawa et al., 2009). Furthermore,
highly purified SitC (MntC) co-localized with and induced TLR2
(Kurokawa et al., 2009; Muller et al., 2010), showing direct
evidence of IRLP recognition by the host immune system.
In vivo studies have revealed a paradox in the expression of
lipoproteins during infection. Of particular note, sublethal chal-
lenge of mice with an lgt mutant resulted in increased mortality
relative to the wild-type infection, suggesting that lipoproteins
are required to initiate the host innate immune response (Bubeck
Wardenburg et al., 2006; Schmaler et al., 2009, 2010). Conversely,
the expression of lipoproteins increases bacterial burden dur-
ing persistent tissue infections, shown to be due to their role
in enhancing staphylococcal survival through iron acquisition
(Schmaler et al., 2009, 2010). While SitC (MntC) represents
the predominant iron-regulated staphylococcal lipoprotein, as
previously discussed, S. aureus lacking SitC (MntC) can still stim-
ulate TLR2 (Kurokawa et al., 2009). Given that staphylococcal
lipoproteins involved in the acquisition of iron are highly upreg-
ulated during iron starvation and expressed in vivo and in vitro
(Morrissey et al., 2000; Sebulsky and Heinrichs, 2001; Dale et al.,
2004a,b; Skaar et al., 2004a,b; Allard et al., 2006; Hempel et al.,
2011), they together likely serve as important PAMPs for TLR2
recognition. Together these results suggest that the elaboration
of multiple and sometimes redundant IRLPs may ensure staphy-
lococcal survival in an otherwise inflamed host, providing an
intriguing option for the development of potential therapeutics.
CLINICAL APPLICATIONS
Given their cell surface exposure, propensity to be expressed in
vivo and corresponding immunogenicity, the IRLPs represent a
tangible target for staphylococcal vaccine development. Indeed,
both Sanofi-Pasteur/Syntiron and Novartis are including IRLPs
in pre-clinical multivalent vaccine preparations. A discussion of
S. aureus vaccine attempts is beyond the scope of this review,
so we refer the reader to several excellent, recent reviews on the
subject (Otto, 2010; Daum and Spellberg, 2012; DeDent et al.,
2012; Patti, 2011; Proctor, 2011). The focus of published passive
and active immunization efforts targeting iron acquisition sys-
tems thus far have centered on the Isd cell wall anchored proteins
IsdA, IsdB, and IsdH, with promising results in animal models of
S. aureus infection (Clarke et al., 2006; Kuklin et al., 2006; Ebert
et al., 2010; Kim et al., 2010; Ster et al., 2010; Arlian and Tinker,
2011; Daum and Spellberg, 2012; DeDent et al., 2012; Harro et al.,
2012). Of the Isd proteins, Merck and Intercell took their single-
antigen IsdB vaccine, V710 (Kuklin et al., 2006), through phase I
clinical trials, demonstrating that the vaccine was immunogenic
within 2 weeks of administration and had a good safety profile
in humans (Harro et al., 2010, 2012). Phase II/III clinical trials
were terminated following a statistical review of the data suggest-
ing that V710 was unlikely to demonstrate a significant benefit
to patients (Patti, 2011). Many experts in the field are now sug-
gesting that as opposed to a single-antigen vaccine, multivalent
strategies, at least in humans, offer the greatest chance for suc-
cess. In support of this recommendation, IsdA and IsdB, when
combined with two additional S. aureus surface antigens, offered
greater protective immunity, at least in rodent models, than when
the animals were immunized with the individual antigens alone
(Stranger-Jones et al., 2006).
In addition to the challenges in mounting an antibody
response against the staphylococci (Foster, 2005), the functional
redundancy (in terms of supplying a vital iron source to the
bacteria) and strain variation in iron-regulated proteins suggests
multiple systems should be targeted through a combinatorial vac-
cine. Indeed, the reduced fitness of sir hts sst mutants relative
to single or double mutants recommends targeting multiple iron
acquisition lipoproteins to inhibit growth (Beasley et al., 2011).
Moreover, effective antibody-based approaches may require anti-
bodies that inhibit protein function, in addition to, or in lieu of,
being opsonic. Certainly, protective anti-IsdA and anti-IsdB anti-
bodies appear to function by inhibiting heme acquisition (Kim
et al., 2010). Thus, puzzling out the substrate specificities, expres-
sion patterns, presence/absence in different strains or species, and
relevance, alone or in combination, to in vivo growth/infectivity
is paramount toward effective use of the IRLPs as therapeutic tar-
gets. Aside of vaccine strategies, other avenues do exist for taking
advantage of iron acquisition systems for therapeutic interven-
tion. It is possible that knowledge on the substrate specificities,
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along with detailed structural information, will lead to the use of
the uptake systems as portals for toxic “trojan horse” compounds
that kill or limit growth of the staphylococci.
CONCLUDING REMARKS
IRLPs play an essential role in the acquisition of iron, and con-
sequently the in vivo survival of the staphylococci. Paradoxically,
these lipoproteins are also strongly immunogenic, inducing an
inflammatory response through recognition by TLR2-MyD88. A
balance, therefore, exists between the surface display of multi-
ple IRLPs and evading immune recognition by the host. Both
of these characteristics make IRLPs a good choice of targets
for vaccine development, and the formulation of a combina-
torial vaccine targeting multiple iron uptake systems has been
suggested to maximize efficacy. Further research is required to
identify the source of the activity responsible for the N-acylation
of staphylococcal lipoproteins. More work should also focus on
obtaining high-resolution structural information on each of the
proteins discussed here. As iron represents an essential element
to survival, the IRLPs remain at the interface of pathogene-
sis and potential therapeutic control of the often pathogenic
staphylococci.
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